Surgical management of BCG vaccine-induced regional axillary lymphadenitis in HIV-infected children

South African Journal of Surgery

Volumn 46, Issue 2, 2008, Pages 52-55

  Juzi, J T ^a   Sidler, D ^a   Moore, S W ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

ARTICLE; AXILLA; COMORBIDITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; LYMPHADENITIS; MALE; RETROSPECTIVE STUDY;

AXILLA; BCG VACCINE; COMORBIDITY; FEMALE; HIV INFECTIONS; HUMANS; INFANT; LYMPHADENITIS; MALE; RETROSPECTIVE STUDIES;

EID: 47149105527     PISSN: 00382361     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Marshall JB. Tuberculosis of the gastrointestinal tract and peritoneum. Am J Gastroenterol 1993; 88: 989-997.
2. Johnson CAC, Hill ID, Bowie MD. Abdominal tuberculosis in children. S Afr Med J 1987; 72: 20-22.
3. Fourie PB. BCG vaccination and the EPI. S Afr Med J 1987; 72: 323-326.
4. Kabra SK, Lodha R, Seth V. Some current concepts on childhood tuberculosis. Indian J Med Res 2004; 120: 387-397.
5. Schaaf HS, Beyers N, Gie RP, et al. Respiratory tuberculosis in childhood: the diagnostic value of clinical features and special investigations. Pediatr Infect Dis J 1995; 14: 189-194.
6. Hesseling AC, Schaaf HS, Victor T, et al. Resistant Mycobacterium bovis Bacillus Calmette-Guerin disease: implications for management of Bacillus Calmette-Guerin disease in human immunodeficiency virus-infected children. Pediatr Infect Dis J 2004; 23: 476-479.
7. Hesseling AC, Marais BJ, Gie RP, et al. The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children. Vaccine 2007; 25: 14-18.
8. Daoud W. Control of an outbreak of BCG complications in Gaza. Respirology 2003; 8: 376-378.
9. Deeks SL, Clark M, Scheifele DW, et al. Serious adverse events associated with bacille Calmette-Guerin vaccine in Canada. Pediatr Infect Dis J 2005; 24: 538-541.
10. Tastan Y, Arvas A, Demir G, Alikasifoglu M, Gur E, Kiray E. Influence of Bacillus Calmette-Guerin vaccination at birth and 2 months of age on the peripheral blood T-cell subpopulations (gamma/delta and alpha-beta T cell). Pediatr Allergy Immunol 2005; 16: 624-629.
11. Kumar R, Dwivedi A, Kumar P, Kohli N. Tuberculous meningitis in BCG vaccinated and unvaccinated children. J Neurol Neurosurg Psychiatry 2006; 76: 1550-1554.
12. Bald A, Oncu M, Usta S, Yildiz K, Karaguzel A. Therapy of regional lymphadenitis following BCG vaccination. Infection 1991; 19: 414-416.
13. Caglayan S,Yegin O, Kayran K,Timocin N, Kasirga E, Gun M. Is medical therapy effective for regional lymphadenitis following BCG vaccination? Am J Dis Child 1987; 141: 1213-1214.
14. Kuyucu N, Kuyucu S, Ocal B.Tezic T. Comparison of oral erythromycin, local administration of streptomycin and placebo therapy for non-suppurative Bacillus Calmette-Guerin lymphadenitis. Pediatr Infect Dis J 1998; 17: 524-525.
15. Noah PK, Pande D, Johnson B, Ashley D. Evaluation of oral erythromycin and local isoniazid instillation therapy in infants with Bacillus Calmette-Guerin lymphadenitis and abscesses. Pediatr Infect Dis J 1993; 12: 136-139.
16. Close GC, Nasiiro R. Management of BCG adenitis in infancy. J Trop Pediatr 1985; 31: 286.
17. Banani SA, Alborzi A. Needle aspiration for suppurative post-BCG adenitis. Arch Dis Child 1994; 71: 446-447.
18. Hengster P, Solder B, Fille M, et al. Surgical treatment of Bacillus Calmette-Guerin lymphadenitis. World J Surg 1997; 21: 520-523.
19. Cagalayn S, Afrikan A,Yaprak I, Aksoz K, Kansoy S. Management of suppuration in regional lymphnodes secondary to BCG vaccination. Acta Paediatr Jpn 1991; 33: 699-702.